Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic

被引：26
|
作者：
Hansel, K. [1 ]
Patruno, C. [2 ]
Antonelli, E. [1 ]
Dal Bello, G. [3 ]
Napolitano, M. [4 ]
Fabbrocini, G. [5 ]
Grieco, T. [6 ]
Pellacani, G. [6 ]
Fargnoli, M. C. [7 ]
Esposito, M. [7 ]
Piras, V. [8 ]
Zucca, M. [8 ]
Girolomoni, G. [3 ]
Stingeni, L. [1 ]
机构：
[1] Univ Perugia, Dermatol Sect, Dept Med & Surg, Perugia, Italy
[2] Magna Graecia Univ Catanzaro, Sect Dermatol, Hlth Sci Dept, Catanzaro, Italy
[3] Univ Verona, Sect Dermatol & Venereol, Dept Med, Verona, Italy
[4] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy
[5] Univ Naples Federico II, Sect Dermatol, Dept Clin Med & Surg, Naples, Italy
[6] Sapienza Univ Rome, Dermatol Unit, Rome, Italy
[7] Univ LAquila, Dept Biotechnol & Appl Clin Sci, Dermatol, Laquila, Italy
[8] Univ Cagliari, Dept Med Sci & Publ Hlth, Dermatol Clin, Cagliari, Italy
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2022年 / 47卷 / 01期
关键词：
D O I：
10.1111/ced.14862
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：165 / 167
页数：3
相关论文
共 50 条
  • [21] Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study
    Pagan, Angel D.
    David, Eden
    Ungar, Benjamin
    Ghalili, Sabrina
    He, Helen
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (09): : 2378 - 2385
  • [22] Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience
    Sroka-Tomaszewska, Jowita
    Bulinska, Barabara
    Wilkowska, Aleksandra
    Nowicki, Roman J.
    Trzeciak, Magdalena
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 747 - 752
  • [23] Dupilumab treatment in adult patients with moderate to severe atopic dermatitis: A real-world single-center experience from Turkey
    Salman, Andac
    Aktas, Meryem
    Ozkurkcu, Esra
    Sarac, Gonca
    Taskapan, Oktay
    Ergun, Tulin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB144 - AB144
  • [24] COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
    Ungar, Benjamin
    Glickman, Jacob W.
    Golant, Alexandra K.
    Dubin, Celina
    Marushchak, Olga
    Gontzes, Alyssa
    Mikhaylov, Daniela
    Singer, Giselle K.
    Baum, Danielle
    Wei, Nancy
    Sanin, Antonio
    Gruenstein, Diana
    Lebwohl, Mark G.
    Pavel, Ana B.
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (01): : 134 - 142
  • [25] Efficacy of Dupilumab on Different Phenotypes of Adult with Moderate-to-Severe Atopic Dermatitis in Taiwan: A Real-World Study
    Yang, Chin-Yi
    Lai, Po-Ju
    Chen, Chun-Bing
    Chan, Tom C.
    Hui, Rosaline Chung-Yee
    Huang, Yu-Huei
    Tseng, Han-Chi
    Lin, Shang-Hung
    Lu, Chun-Wei
    Lee, Hua-En
    Lin, Jing-Yi
    Chi, Min-Hui
    Tsai, Ming-Feng
    Hwang, Yih-Shiou
    Wang, Chuang-Wei
    Chu, Chia-Yu
    Chung, Wen-Hung
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [26] Laboratory markers of dupilumab patients with moderate-to-severe atopic dermatitis: a single-center, real-world study
    Hawkins, K.
    Sharma, D.
    Shokrian, N.
    Piontkowski, A.
    Ungar, B.
    Guttman-Yassky, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S162 - S162
  • [27] Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study
    Hagino, Teppei
    Hamada, Risa
    Yoshida, Mai
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    PHARMACEUTICALS, 2024, 17 (04)
  • [28] Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea
    Lee, Dong Hun
    Ko, Hyun Chang
    Na, Chan Ho
    Roh, Joo Young
    Park, Kui Young
    Park, Young Lip
    Park, Young Min
    Park, Chang Ook
    Park, Chun Wook
    Bae, Youin
    Seo, Young-Joon
    Son, Sang Wook
    Ahn, Jiyoung
    Jung, Hye Jung
    Yang, Jun-Mo
    Won, Chong Hyun
    Yoo, Kwang Ho
    Lew, Bark Lynn
    Lee, Sang Eun
    Lee, Sung Yul
    Lee, Seung-Chul
    Lee, Yang Won
    Lee, Ji Hyun
    Jang, Yong Hyun
    Jeon, Jiehyun
    Han, Tae-Young
    Cho, Sang Hyun
    ANNALS OF DERMATOLOGY, 2022, 34 (02) : 157 - 160
  • [29] Efficacy, Safety, and Early Relapse After Cessation of Upadacitinib Versus Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Real-World Study in China
    Zhu, Jiling
    Wu, Hanwen
    Ye, Yahui
    Xu, Qiuyang
    Shao, Junyi
    Bai, Zicheng
    Zhou, Yiwen
    Li, Zhenyan
    Liu, Jingjing
    Li, Zhiming
    DERMATITIS, 2024, 35 (06) : 636 - 645
  • [30] Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-Up
    Navarro-Trivino, Francisco Jose
    Galan-Gutierrez, Manuel
    Hita, Jose Carlos-Armario
    Ruiz-Villaverde, Ricardo
    Dominguez-Cruz, Javier
    Pereyra-Rodriguez, Jose Juan
    DERMATITIS, 2024, 35 : S55 - S61
12345